4 Active TrialsSmall Practice
12 MS centers statewide · Ranked #3 in Virginia for clinical trials
At a glance
What kind of place is this?
AI summary of this centre's website
One Doctor Relationship
You're looking at a dedicated MS practice in Vienna that focuses on neurology care in one local location.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services1/5
Clinical Trials & Research3/5
Insurance & Navigation Help1/5
Scheduling & Virtual Care1/5
About Multiple Sclerosis Center of Greater Washington
AI summary of this centre's website
This is a dedicated MS practice in a single-location setting, so your care is centered in one local office.
Multiple Sclerosis Center of Greater Washington provides neurology care for people seeking MS-focused support in Vienna, VA.
Good to know
- Single-location practice in Vienna, VA
Multiple Sclerosis Center of Greater Washington is a dedicated MS practice in Vienna, Virginia. It offers neurology care with a focused, local approach to care. Patients looking for in-person neurology support can find a small, specialized practice here.
Services & Treatments
How They Treat It
Neurology
Research & Clinical Trials
This center is currently involved in 4 clinical trials — ranked #3 in Virginia for active trials
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Closed to new patientsPhase 3
FenebrutinibTeriflunomidePlacebo
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Closed to new patientsPhase 3
RemibrutinibTeriflunomide
Insurance & Access
Insurance & Support
Related MS Research
Recent studies relevant to this center's focus areas
FAQs from Multiple Sclerosis Center of Greater Washington
It is described as a dedicated MS practice, and neurology is listed as a service. That makes it a focused option for patients seeking MS-related neurological care.
This is a single-location practice in Vienna, VA. Your care is centered in one office rather than across multiple sites.
Care is provided in-person at the Vienna location.
For scheduling or messaging, contact the office directly.
Compare Virginia MS Centers
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
Multiple Sclerosis Center of Greater Washington Vienna | Dedicated MS Practice | — | — | 2/5 |
Neurology Center of Fairfax Fairfax | Regional Neurology Group | — | — | 2.8/5 |
Riverside Hampton Roads Neurology MS Center Newport News | Dedicated MS Practice | — | — | 4/5 |
UVA Multiple Sclerosis and Clinical Neuroimmunology Center Charlottesville | Academic MS Center | — | — | 3.4/5 |
| Dedicated MS Practice | — | — | 3/5 | |
| Dedicated MS Practice | — | — | 2.6/5 |
Multiple Sclerosis Center of Greater Washington
Vienna • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
2/5
Neurology Center of Fairfax
Fairfax • Regional Neurology Group
Infusion
—
Virtual
—
Experience
2.8/5
Riverside Hampton Roads Neurology MS Center
Newport News • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
4/5
UVA Multiple Sclerosis and Clinical Neuroimmunology Center
Charlottesville • Academic MS Center
Infusion
—
Virtual
—
Experience
3.4/5
Roanoke Area Multiple Sclerosis Center
Salem • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
3/5
Neurology Consultants of Tidewater MS Center
Norfolk • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
2.6/5
MS Centers Across the U.S.
Click a state to browse its MS treatment centers.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.

